EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Alveolar Hyperoxia and Exacerbation of Lung Injury in Critically Ill SARS-CoV-2 Pneumonia

Ahilanandan Dushianthan iD, Luke Bracegirdle iD, Rebecca Cusack iD, Andrew F Cumpstey iD, Anthony D Postle, Michael P W Grocott iD

Medical Sciences · 2023

DOI: 10.3390/medsci11040070 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Sciences, 2023. Verfasst von Ahilanandan Dushianthan und 5 weiteren Autor:innen. Beteiligte Einrichtung: NIHR Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK. Hauptthemen laut MEDLINE: COVID-19, Hyperoxia, Lung Injury, Respiratory Distress Syndrome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute hypoxic respiratory failure (AHRF) is a prominent feature of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) critical illness. The severity of gas exchange impairment correlates with worse prognosis, and AHRF requiring mechanical ventilation is associated with substantial mortality. Persistent impaired gas exchange leading to hypoxemia often warrants the prolonged administration of a high fraction of inspired oxygen (FiO2). In SARS-CoV-2 AHRF, systemic vasculopathy with lung microthrombosis and microangiopathy further exacerbates poor gas exchange due to alveolar inflammation and oedema. Capillary congestion with microthrombosis is a common autopsy finding in the lungs of patients who die with coronavirus disease 2019 (COVID-19)-associated acute respiratory distress syndrome. The need for a high FiO2 to normalise arterial hypoxemia and tissue hypoxia can result in alveolar hyperoxia. This in turn can lead to local alveolar oxidative stress with associated inflammation, alveolar epithelial cell apoptosis, surfactant dysfunction, pulmonary vascular abnormalities, resorption atelectasis, and impairment of innate immunity predisposing to secondary bacterial infections. While oxygen is a life-saving treatment, alveolar hyperoxia may exacerbate pre-existing lung injury. In this review, we provide a summary of oxygen toxicity mechanisms, evaluating the consequences of alveolar hyperoxia in COVID-19 and propose established and potential exploratory treatment pathways to minimise alveolar hyperoxia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HyperoxiaLung InjuryRespiratory Distress SyndromeHumansSARS-CoV-2Critical IllnessOxygenHypoxiaInflammation

Stichwörter der Autor:innen

COVID-19hyperoxiaintensive carelung injuryoxygen therapy

Substanzen

Oxygen

Autor:innen und Institutionen

  • NIHR Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK.
  • Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK.

ORCID-Profile: Ahilanandan Dushianthan, Luke Bracegirdle, Rebecca Cusack, Andrew F Cumpstey, Michael P W Grocott

Zitieren

APA

Dushianthan, A., Bracegirdle, L., Cusack, R., Cumpstey, A. F., Postle, A. D., & Grocott, M. P. W. (2023). Alveolar Hyperoxia and Exacerbation of Lung Injury in Critically Ill SARS-CoV-2 Pneumonia. Medical Sciences. https://doi.org/10.3390/medsci11040070

Vancouver

Dushianthan A, Bracegirdle L, Cusack R, Cumpstey AF, Postle AD, Grocott MPW. Alveolar Hyperoxia and Exacerbation of Lung Injury in Critically Ill SARS-CoV-2 Pneumonia. Medical Sciences. 2023. doi:10.3390/medsci11040070

BibTeX
@article{Dushianthan2023,
  author = {Dushianthan, Ahilanandan and Bracegirdle, Luke and Cusack, Rebecca and Cumpstey, Andrew F and Postle, Anthony D and Grocott, Michael P W},
  title = {Alveolar Hyperoxia and Exacerbation of Lung Injury in Critically Ill SARS-CoV-2 Pneumonia},
  journal = {Medical Sciences},
  year = {2023},
  doi = {10.3390/medsci11040070}
}
Kostenlos starten →